Bioniche Life Sciences Inc. is a leading, fully-integrated biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide.
The information contained in the Company’s news releases was accurate at the time of posting on this website, but the information may be superseded by subsequent corporate disclosures.
For recent media coverage of Bioniche Life Sciences Inc. click here >>
May 13, 2013
Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health Business
May 8, 2013
Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results
May 4, 2013
Bioniche Life Sciences Inc. Responds to Dissident Request for Shareholder Meeting
Bioniche Key Facts
President & CEO:
TSX stock symbol:
vaccines, replacement of antibiotics
One Health: E. coli O157 vaccine, other veterinary biopharmaceutical products to address diseases in livestock which may have an effect on human health